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Abstract
Motivated by the genomic application of expression quantitative trait loci (eQTL) map-
ping, we propose a new procedure to perform simultaneous testing of multiple hypotheses
using Bayes factors as input test statistics. One of the most significant features of this
method is its robustness in controlling the targeted false discovery rate (FDR) even under
misspecifications of parametric alternative models. Moreover, the proposed procedure is
highly computationally efficient, which is ideal for treating both complex system and big
data in genomic applications. We discuss the theoretical properties of the new procedure
and demonstrate its power and computational efficiency in applications of single-tissue and
multi-tissue eQTL mapping.
1 Introduction
With the emergence of high-throughput experiment technologies, false discovery rate (FDR) con-
trol (Benjamini and Hochberg, 1995) has become a standard statistical practice in many genomic
applications. Despite the importance of the FDR control procedures, the overall power in a mul-
tiple testing problem is largely determined by the test statistics employed. In many application
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areas, the practitioners are facing increasingly complex systems in which many factors must
be accounted for, and their relationships are typically nontrivial. Consequently, it is extremely
difficult to describe these systems mathematically without parametric modeling, and it is even
more difficult to determine powerful testing statistics. Bayesian models have exhibited some
great advantages in such complex settings and have become increasingly popular. Within the
Bayesian hierarchical modeling framework, Bayesian FDR control is conceptually straightforward
and easy to implement in a sound decision-theoretic framework, as illustrated by Newton et al.
(2004), Mu¨ller et al. (2006), Whittemore (2007), Ji et al. (2008). Nevertheless, its practical usage
is often hindered primarily by two factors: first, its lack of robustness due to the heavy reliance on
parametric assumptions in alternative model specifications (Opgen-Rhein and Strimmer, 2007)
and second, its expensive computational cost.
This paper addresses both issues and proposes a novel Bayesian FDR control procedure motivated
by the genomic application of expression quantitative trait loci (eQTL) mapping, where tens of
thousands association tests are simultaneously performed. In the context of eQTL mapping,
parametric models are particularly preferred because they provide necessary flexibility to i)
control unknown confounding/batch effects; ii) incorporate prior knowledge of relevant genomic
annotations; and iii) handle complex data structure, e.g., in multi-tissue eQTL mapping. Those
parametric models for eQTL mapping often contain hierarchical structures with natural Bayesian
interpretations (Flutre et al., 2013). As a unique feature, our proposed procedure directly works
with Bayes factors (Kass and Raftery, 1995), which are often considered to be the natural test
statistics within the Bayesian framework due to the likelihood principle. Most significantly,
our proposed procedure controls the target FDR level even when the alternative models are
misspecified, which is a property that is currently missing from most available Bayesian and
parametric model-based multiple testing approaches.
In theory, it is always possible to convert a Bayes factor to a corresponding p-value (by treat-
ing the Bayes factor as a regular test statistic) and to apply the p-value based FDR control
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procedures (Benjamini and Hochberg, 1995, Storey, 2002, 2003, Storey and Tibshirani, 2003,
Storey et al., 2004, Storey, 2007), a strategy known as the Bayes/Non-Bayes compromise (Good,
1992). However, in practice, the conversion often relies on permutation procedures and their
computational cost can be extremely high when treating complex models and/or large data
sets, therefore not suitable to apply to the genomic data at the genome-wide scale. In fact,
the computational efficiency is a general challenge for any multiple testing procedure that
relies on permutation p-values. In comparison, for a wide range of parametric models, it
has been demonstrated that Bayes factors can be computed or accurately approximated in a
highly efficient manner (Kass and Raftery, 1995, Raftery, 1996, DiCiccio et al., 1997, Johnson,
2005, Servin and Stephens, 2007, Liang et al., 2008, Johnson, 2008, Saville and Herring, 2009,
Flutre et al., 2013, Wen, 2014, Wen and Stephens, 2014). Based on these results, the computa-
tional resources required by our proposed procedure for controlling FDR are trivial, which makes
it ideal for treating both complex models and big data in genomic applications.
The remainder of the paper is organized as follows: we first provide the necessary background
regarding FDR controls within the Bayesian framework in the Section 2, and then proceed to
describe our novel Bayesian FDR control method in the Section 3. In the Section 4 and 5, we
illustrate the proposed approach in applications of single-tissue and multi-tissue eQTL mapping,
respectively. Finally, we summarize our findings and discuss future directions in the Section 6.
2 Notation and Setup
Throughout this paper, we consider multiple testing problems under a general hierarchical
mixture model setting, which is generally assumed in both Bayesian and frequentist frame-
works (Efron et al., 2001, Storey, 2003, Newton et al., 2004, Genovese and Wasserman, 2004,
Mu¨ller et al., 2006). Consider a set of m hypotheses for simultaneous testing. Let Y i denote the
data collected for the i-th test, and let the complete collection of the observed data from all m
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tests be denoted by Y := {Y 1, . . . ,Y m}. Suppose that each Y i is generated from either a null
model or some alternative model, namely,
Y i ∼ p
Zi
i , (2.1)
where Zi is a latent indicator that denotes the true generating distribution. Note that we do not
require all the hypotheses to share the same null or alternative models. The vector of the latent
indicators, Z := (Z1, . . . , Zm), is of primary interest for inference, and the commonality of all
the tests lies on the assumption
Zi | π0
i.i.d
∼ Bernoulli (1− π0) , i = 1, ..., m. (2.2)
In particular, the parameter π0 represents the proportion of the data generated from the respec-
tive null hypothesis and is typically unkonwn. Finally, we assume that the tests are mutually
independent conditional on π0, i.e.,
Pr(Z | Y , π0) =
m∏
i=1
Pr(Zi | Y , π0) =
m∏
i=1
Pr(Zi | Y i, π0). (2.3)
Under the above hierarchical mixture model, the simultaneous hypothesis testing can be framed
as a joint decision problem with respect to Z. Let δi denote a decision (0 or 1) on Zi based on all
the observed data, and define D :=
∑m
i=1 δi. Following the formulation of Mu¨ller et al. (2006), we
define the False Discovery Proportion (FDP) as the proportion of false discoveries among total
discoveries, i.e., FDP :=
∑m
i=1 δi(1−Zi)
D∨1
. The Bayesian False Discovery Rate is naturally defined as
the expectation of FDP conditional on Y , i.e.,
FDR := E(FDP | Y) =
∑m
i=1 δi (1− vi)
D ∨ 1
, (2.4)
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where the conditional expectation is taken with respect to Z , and vi := Pr(Zi = 1 | Y).
Moreover, the frequentist control of the False Discovery Rate focuses on the quantity
FDR := E(FDR) = E [E(FDP | Y)] , (2.5)
where the additional expectation is taken with respect to Y over (hypothetically) repeated ex-
periments. It is important to note that controlling the Bayesian FDR is a sufficient but not
necessary condition to control the corresponding frequentist FDR; thus the Bayesian FDR con-
trol is more stringent in theory. For measuring type II errors in a multiple testing setting, the
False Non-discovery Proportion (FNP), the Bayesian False Non-discovery Rate (FNR) and the
frequentist FNR are defined in a similar fashion.
Bayesian FDR control procedure is carried out by evaluating the posterior probability vi for each
test, i.e.,
vi =
∫
Pr(Zi = 1 | Y , π0) p(π0 | Y) d π0. (2.6)
In particular, the data from all tests jointly affect p(π0 | Y) and thereby impact the posterior
distribution of each individual Zi. However, conditional on π0, Pr(Zi = 1 | Y , π0) can be
computed independently, i.e.,
Pr(Zi = 1 | Y , π0) = Pr(Zi = 1 | Y i, π0) =
(1− π0) BFi
π0 + (1− π0) BFi
, (2.7)
where BFi is the null-based Bayes factor (Liang et al., 2008) defined by
BFi :=
p(Y i | Zi = 1)
p(Y i | Zi = 0)
=
p1i (Y i)
p0i (Y i)
. (2.8)
Particularly, in computing BFi, all the potential nuisance parameters in the parametric models
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(null or alternative) are integrated out with respect to their prior distributions (Kass and Raftery,
1995). As demonstrated by Newton et al. (2004) and Mu¨ller et al. (2006), the Bayesian FDR
control is based on the following natural decision rule,
δ∗i (t) = I (vi > t) , (2.9)
i.e., the null hypothesis is rejected if the posterior probability that the observed data is generated
from the alternative is high. For a pre-defined FDR level α, the threshold tα in (2.9) is determined
by
tα = argmin
t
(∑m
i=1 δ
∗
i (t)(1− vi)
D(t) ∨ 1
≤ α
)
(2.10)
Furthermore, Mu¨ller et al. (2004) demonstrated that the decision rule (2.9) is optimal in the
sense that it minimizes the corresponding FNR while controlling for the FDR.
3 Robust Control of Bayesian FDR
Although the Bayesian FDR control is conceptually straightforward, its practical performance is
susceptible to alternative model misspecifications. In comparison, the p-value based frequentist
FDR control procedures demand only adequate behavior of p-values under the null models and
generally ensure targeted FDR control levels, regardless of the distribution of p-values under
the assumed alternatives. This robustness property against type I error is often desirable in the
hypothesis testing context.
In this section, we provide a detailed discussion of this topic and provide intuitions and theoretical
justifications for a new Bayesian FDR control procedure. It should be noted that our notion of
“ model misspecification” includes the cases of prior misspecification in Bayesian settings.
6
3.1 General Approach
The specifications of parametric (null and alternative) models impact Bayesian FDR control in
the following two aspects.
First, the computation of the Bayes factors relies on the model assumptions of p0i and p
1
i . In
hypothesis testing, the “correctness” of Bayes factors is formally characterized by a concept
known as consistency in model comparisons, i.e., with sufficiently large sample size, Bayes factor
→ 0 if the data is truly generated from the null model and → ∞ if the data is generated
from the alternative model. Intuitively, to prevent inflation of the pre-defined FDR level, which
concerns the behavior of the testing procedure under the null, the consistency of the Bayes
factors is only required under the null models. Such a condition is easy to satisfy (and also easy
to check) as long as the null model is correctly specified. In contrast, when the alternative model
is misspecified (which is almost certain in practice), the Bayes factor might not be consistent
under the alternative. Nonetheless, as we will demonstrate later, it does not inflate the FDR but
only affects the power/FNR given the true π0. We also note that the assumption regarding the
consistency of the Bayes factors under null models is analogous to the uniformity assumption of
the null p-values, i.e., both are valid only if the null models are correctly specified. In summary,
we expect that the null models are correctly specified and allow imperfect specification of the
alternative models . Nevertheless to ensure decent power in testing, it is preferred that the Bayes
factor is far greater than 1 under the alternative scenario and especially in an asymptotic scenario.
Importantly, the consistency property of the Bayes factors under the null models implies that
the Bayes factors from the alternative models are stochastically dominant over the Bayes factors
from the null models.
Second, the inference of p(π0 | Y) from the mixture model is sensitive to the alternative model
specifications and therefore affects the Bayesian FDR control: if π0 is systematically under-
estimated, the pre-defined Bayesian FDR level is inflated; conversely, over-estimating π0 results
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in a conservative procedure that loses power but maintains the desired FDR level. To avoid
under-estimation of π0 in all circumstances, we attempt to find a robust upper bound estimator
for π0, denoted by πˆ0(Y), such that under the sampling distribution of Y and for all possible
values of π0,
Pr (πˆ0(Y) ≥ π0 | π0) −→ 1, as the number of the true null tests is sufficiently large. (3.1)
The conditional probability expression emphasizes that the upper bound property of πˆ0(Y) holds
true for arbitrary π0 values. Given (3.1), for arbitrary prior distributions on π0, it follows that
Pr(π0 ≤ πˆ0(Y) | Y) −→ 1, (3.2)
i.e., πˆ0 forms a probability upper bound of the posterior distribution of π0, whose corresponding
prior distribution can be arbitrary.
The key to our approach is to ensure condition (3.1) even if the alternative models are misspec-
ified. (It should be clear that such an upper bound does exist: e.g., the trivial bound πˆ0(Y) ≡ 1
satisfies this requirement; however, it is too conservative to be useful.) In this paper, we rely
on results from asymptotic theories to find the desired πˆ0 estimates while utilizing virtually no
assumptions from the alternative models. As a consequence, the resulting πˆ0 may not be optimal
in terms of “precision” (with respect to the truth), but it certainly has great appeal in guarding
the pre-defined FDR level against alternative model misspecifications.
Based on the above discussion, we now define a new quantity
vˆi := Pr(Zi = 1 | Y i, πˆ0) =
(1− πˆ0)BFi
πˆ0 + (1− πˆ0)BFi
, (3.3)
which is consistently more conservative than the underlying true vi. We propose a conservative
Bayesian FDR control procedure that essentially replaces vi with vˆi in (2.9). Specifically, we
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denote the new decision rule δ†i (t) := I (vˆi > t) and D
†(t) :=
∑m
i=1 δ
†
i (t).
With a stronger assumption that assumes sufficiently large sample size for each test, we are able
to show the following theoretical result for the proposed approach:
PROPOSITION 1. Assuming that the following conditions are satisfied:
1. the Bayes factors are consistent under the true null models
2. there exists an upper bound point estimator πˆ0(Y) such that
Pr(π0 ≤ πˆ0(Y) | π0)→ 1, ∀ π0 ∈ (0, 1),
as the number of the true null tests is sufficiently large.
The decision rule δ†i (t) := I (vˆi > t) controls the frequentist FDR at level α with the rejection
threshold
t†α = argmin
t
(∑m
i=1 δ
†
i (t)(1− vˆi)
D†(t) ∨ 1
≤ α
)
,
as the sample size per test and the number of the true null tests are sufficiently large. Furthermore,
the Bayesian FDR can be consistently controlled in the sense that
Pr
(
FDR ≤ α
)
−→ 1.
The proof is based on the above discussion and the full details are given in the appendix A.
Proposition 1 specifies two asymptotic conditions: both the number of true null tests and the
sample size per test are required to be large. The large number of the true null tests ensures the
probabilistic nature of the upper bound property of πˆ0. This condition is also implicitly required
for p-value based FDR control procedures to guarantee the uniform distribution of p-values from
the true null tests. (This point is demonstrated by the connection between the QBF procedure
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and the Storey’s q-value procedure in the section 3.2.2). It is important to note that this condition
does not impose any restriction on the proportion of the true null tests, i.e., π0. The condition for
sample size per test is used for proving the stringent Bayesian FDR control criteria. Although we
believe that the result of the Proposition 1 holds true even without this particular large sample
requirement (especially for controlling frequentist FDR), the proof becomes extremely difficult
and our attempt is unsuccessful. Nevertheless in practice, we observe that the stated decision
rule works well for very modest sample sizes: illustrations are given in the simulation study and
the real data application where the sample sizes are both quite limited.
3.2 Upper Bound Estimation of π0 using Bayes Factors
In this section, we describe two methods that can robustly estimate πˆ0 that satisfy assumption 2
in the Proposition 1 using only Bayes factors. The two methods share a simple intuition based on
the stochastic orderings: for Bayes factors with reasonable powers, the smaller values are more
likely generated from the null models. Theoretically, they both rely on the weak law of large
numbers (WLLN) to ensure the upper bound property stated in (3.1). Note that both approaches
require the number of the simultaneous tests is sufficiently large, but impose no restrictions on
sample sizes in each test. R code code implementing the described computational procedures is
made freely available at https://github.com/xqwen/bfdr.
3.2.1 Sample Mean based Estimator
We first introduce an estimation procedure for πˆ0 using the sample mean of the observed Bayes
factors. This procedure, named the EBF-procedure, is based on the following Lemma:
LEMMA 1. A well-defined Bayes factor satisfies
E(BF | H0) = 1.
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The proof of the Lemma is trivial from the definition of the Bayes factor.
Intuitively, under some suitable conditions and by the large sample theory, the Lemma 1 implies
that the sample means of the Bayes factors from the true null models converge to 1. On the
other hand, the Bayes factors from the true alternative models with reasonable powers should
be, on average, greater than 1 (i.e., favoring the alternative over the null models). Therefore, the
sample mean of the observed Bayes factors carries information regarding the mixture percentage.
We give a detailed description of the EBF procedure below:
1. Sort all observed Bayes factors in ascending order,
BF(1),BF(2), . . . ,BF(m)
2. Find
d0 = argmax
d
(
1
d
d∑
i=1
BF(i) < 1
)
(3.4)
3. Estimate πˆ0 by
πˆ0 =
d0
m
(3.5)
Essentially, this procedure searches for the largest proportion of tests with mean Bayes factors
less than 1. We demonstrate in Lemma 2 and Proposition 2 that the EBF procedure produces
the upper bound estimate of π0 required by the Proposition 1.
LEMMA 2. In the case π0 = 1, the EBF procedure estimates πˆ0
P
−→ 1, provided that the number
of tests is sufficiently large.
The proof is simply based on the law of large numbers, and the full details are given in the
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appendix B.
PROPOSITION 2. For a mixture of null and alternative models, the estimate by the EBF
procedure satisfies
Pr(πˆ0 ≥ π0 | π0)→ 1,
provided that the number of the null tests is sufficiently large.
The Proposition 2 is trivially followed from Lemma 2, and the detailed argument is provided in
the appendix C.
The EBF procedure also allows the study of some of the general properties of Bayesian FDR
control. Here, we show one interesting example: if a single Bayes factor exceeds a certain
threshold, the corresponding null hypothesis can be rejected with respect to a targeted FDR level
without the explicit evaluation of πˆ0. We call this threshold the automatic rejection threshold of
Bayes factors in multiple testing. We have the following corollary concerning one such automatic
rejection threshold:
COROLLARY 1. Under the settings stated in Proposition 1 and at the FDR level α, if a Bayes
factor exceeds m/α, the EBF procedure automatically rejects the corresponding null hypothesis.
The proof is trivially based on the estimate of πˆ0 by the EBF procedure and equation (2.7); we
give the details in the appendix D. Most interestingly, the automatic rejection threshold, m/α,
clearly resembles Bonferroni corrections for p-values.
3.2.2 Sample Quantile based Estimator
Alternatively, we can estimate πˆ0 using the sample quantile information based on the distribution
of Bayes factors under the null models. Let F 0i (x) and F
1
i (x) denote the cumulative distribution
functions of BFi under the null and the true (unknown) alternative models, respectively. Suppose
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that
F 0i (qi,γ) = γ, (3.6)
i.e., qi,γ is the γ-quantile of BFi under the null model. Consider the sample mean of the inde-
pendent indicators I(BFi ≤ qi,γ), for i = 1, ..., m. By Chebyshev’s weak law of large numbers, it
follows that
1
m
m∑
i=1
I(BFi ≤ qi,γ)
P
−→ π0γ +
1− π0
m
m∑
i=1
F 1i (qi,γ). (3.7)
Note that if γ is small and/or F 0i (x) and F
1
i (x) are well separated, the contribution from the
F 1i (qi,γ) terms should also be small. This is because Bayes factors computed using data from
the alternative models are stochastically dominant over the Bayes factors evaluated using data
generated from the null models, a property implied by the consistency of the Bayes factors under
the null models. Based on (3.7), we propose an estimating algorithm, named the QBF procedure,
to estimate πˆ0. We summarize the details of the QBF procedure and its theoretical properties
in the following proposition:
PROPOSITION 3. For a given γ, the QBF-procedure estimates
πˆ0 =
∑m
i=1 I(BFi ≤ qi,γ)
mγ
. (3.8)
As the number of the null tests is sufficiently large, it follows that
Pr(πˆ0 ≥ π0 | π0)→ 1.
The proof follows trivially from (3.7) by ignoring the contribution from the term 1−pi0
m
∑m
i=1 F
1
i (qi,γ)
on the right-hand side.
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It should be noted that the QBF-procedure is connected with what was proposed by Storey et al.
(2004): treating BFi as a test statistic and denoting its p-value by pi, under the null model, it
follows that,
BFi ≤ qi,γ ⇔ pi > 1− γ. (3.9)
This yields an equivalent representation of (3.8):
πˆ0 =
∑m
i=1 I(pi > 1− γ)
mγ
, (3.10)
which is the exact formula proposed in Storey et al. (2004).
Based on (3.7), it can be concluded that the QBF procedure generates an upper bound estimate
of π0 using any γ ∈ (0, 1) asymptotically. However, for Bayes factors with reasonable power,
taking smaller γ values yields relatively tighter upper bounds on π0 (because of the relatively
small contribution from F 1i (qi,γ)). However if γ is too small, the estimator πˆ0 shown in (3.8)
has undesired large variance for finite m. To strike a balance, we simply set γ = 0.5 for demon-
strations in this paper. (Storey et al. (2004), Storey and Tibshirani (2003) considered the choice
of γ as a problem of bias-variance tradeoff and offered an elegant statistical solution to find an
“optimal” πˆ0 by using multiple γ values. It should be noted that their solution also works in our
case.)
When the quantiles of the Bayes factors under the null models are not directly available, we can
always employ a permutation procedure to estimate them from the samples at hand. According
to (3.9), the permutation procedure is no different statistically than computing permutation
p-values. However, because the quantiles preferred by the QBF procedures are typically not
in the tail area, they can be estimated stably with fewer permutations (than is required for
accurately assessing permutation p-values). Therefore, even in this case, the QBF procedure is
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still computationally efficient. We will fully illustrate this point in our numerical studies.
3.2.3 Comparison of EBF and QBF Procedures
One of the practical differences between the QBF and EBF procedures lies in the relative con-
servativeness of the resulting πˆ0 estimates. We observe that the QBF procedure with γ = 0.5
typically yields a tighter upper bound than the EBF procedure. This might be explained by the
choice of parameter γ in the QBF procedure: smaller γ values yields tighter upper bound esti-
mates. Although the EBF procedure does not explicitly use the quantile information, computing
a sample mean from the null distribution of the Bayes factors requires examining BFi ≤ qi,γ for
γ → 1, i.e., nearly the full distribution is used, and this is seemingly analogous to applying the
QBF procedure with a large γ value.
Once the Bayes factors are computed, the computational cost for the EBF procedure is trivial
in all cases. However, for the QBF procedure, in many situations in which the quantiles of the
Bayes factors under the null models are not directly computable, there is an additional cost of
permutations for quantile estimations.
4 Simulation Study: Single-tissue eQTL Discovery
In this section, we demonstrate the proposed robust Bayesian FDR control method in the context
of eQTL mapping, which aims to identify genetic variants that are associated with gene expression
levels. Specifically, we consider a problem of genome-wide eQTL mapping in a single tissue
for which we can compare the proposed Bayesian approach with the gold-standard frequentist
approach based on permutation p-values .
Particularly, we consider the expression levels of L different genes across the genome are mea-
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sured. For each gene i, we consider ki candidate SNPs, which are typically located in the cis
region of the target gene, and model its expression level yi in the sample using the following
multiple linear regression model,
yi = µi1+
ki∑
j=1
βijgij + ei, ei ∼ N(0, σ
2
i I), (4.1)
where gij denote the genotypes of the j-th candidate genetic variant in gene i, and the gij s are
typically correlated. Based on the linear model, the problem of eQTL discovery can be framed
as testing the following hypothesis for each gene i:
H0 : βij = 0, ∀j vs. H1 : some βij 6= 0,
and we perform the simultaneous hypothesis testing for all L genes. In practice, this QTL
discovery procedure for identifying genes harboring causal associated SNPs in their cis regions
is referred to as eGene discovery.
4.1 Simulation Scheme
We take the real genotype data from a published study (Barreiro et al., 2012) in which n = 85
unrelated individual samples are genotyped genome-wide. We select 10,000 genes from the data
set, where each gene contains 40 to 120 cis-SNPs. Within each gene, genotypes of different
genetic variants are typically correlated at various levels due to linkage disequilibrium (LD). For
each gene, we simulate its phenotype vector according to the linear model (4.1). More specifically,
we fix the intercept term to µi = 1 and residual error variance to σ
2 = 1, and we again assume
that it is known. Under the alternative scenario, for each gene, we randomly sample one to
five associated SNPs , and simulate their genetic effect sizes by drawing from the distribution
βij ∼ N(0, 0.6
2). For each gene, with probabilities π0 and 1− π0 we simulate under the null and
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the alternative scenarios, respectively.
4.1.1 Methods for Comparison
The testing problem encountered in this simulation setting is challenging, primarily because
there is no straightforward test statistic available for the desired gene-level test. To obtain a
valid gene-level p-value for gene i, the standard frequentist approach for eQTL mapping per-
forms ki single SNP association tests and obtain p-values based on the resulting t-statistics.
Subsequently, the minimum of the ki p-values is regarded as the test statistic for the gene i.
(We shall term this test statistic as the min-p statistic). Intuitively, the min-p statistic is most
powerful if there is only a single associated SNP within the candidates (De la Cruz et al., 2010).
Note that the min-p statistic itself is no longer a valid p-value, as it does not follow a uniform
distribution under the null. Furthermore, because of the complex correlation structures among
the genotypes, the null distribution of the min-p statistic is generally unknown. In practice, this
issue is resolved by permuting the individual labels of the phenotype vectors and assessing a
permutation p-value of the min-p statistic, pminp, for each gene. These gene-level p-values are
then plugged into either the Storey procedure (Storey, 2002, 2003) or the Benjamini-Hochberg
(B-H) (Benjamini and Hochberg, 1995) procedure for multiple testing control.
For Bayesian hypothesis testing, we apply a simple Bayesian model proposed by Servin and Stephens
(2007). Briefly, this model explicitly assumes that, under the alternative scenario, exactly one
genetic variant is associated with the expression level, which is similar to the implicit assump-
tion made by the standard frequentist approach. Furthermore , it assumes that every candidate
genetic variant is equally likely to be associated a priori. Under these assumptions, for gene
i, there are exactly ki possible alternative single SNP association models. For each alternative
model with assumed causal SNP ij , a Bayes factor, BFij can be analytically computed as a sim-
ple function of the t-statistic, βˆij/se(βˆij ), by fitting the corresponding simple linear regression
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models (Cox and Hinkley, 1979, Servin and Stephens, 2007, Wakefield, 2009). We then compute
a gene-level Bayes factor by averaging over all single SNP association models, i.e.,
BFi =
1
ki
∑
j
BFij . (4.2)
Note that BFi is a well-defined Bayes factor, and can be directly used in the EBF and the QBF
procedure.
We apply both the EBF and the QBF procedures to analyze the simulated eQTL data. Because
the null distribution of the Bayes factor is not available for the QBF procedure, we use permuta-
tions to estimate the median of the null Bayes factor distribution for each gene. In addition, we
also obtain a permutation p-value by treating BFi as a gene-level test statistic, which is denoted
by pbf , and use it for the B-H and the Storey procedures.
4.2 Simulation Results
We simulate data for π0 = 0.15, ..., 0.95 and create 20 independent replicates for each π0 value.
We apply the Storey and B-H procedures using both pminp and pbf , and use the gene-level Bayes
factors for the EBF and QBF procedures.
We first examine the πˆ0 estimates from the EBF, QBF, and Storey procedures. The estimates
from the QBF and the Storey procedures are based on permutations. We vary the number of
permutations from 100 to 500 to 5000 for γ = 0.5. We average the πˆ0 estimates over replicates
and summarize the results in Table 1. The πˆ0 estimates obtained by the Storey procedure based
on pbf are almost identical to the QBF estimates with the same permutation repeats. To avoid
the redundancy, they are not shown. All the estimates satisfy the upper-bound requirement.
The EBF procedure consistently yields the most conservative estimate. The results from the
QBF and Storey procedures based on pminp are mostly similar, although the QBF estimates
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are slightly less conservative. One important observation is that for all three methods, the πˆ0
estimates have very little variation according to the number of permutations, which is mostly
expected for the reason discussed in section 3.2.2.
πˆ0
π0 Storey (pminp) QBF
100 500 5000 100 500 5000 EBF
0.95 0.978 0.970 0.974 0.977 0.969 0.973 0.982
0.85 0.914 0.910 0.905 0.911 0.907 0.903 0.943
0.75 0.849 0.842 0.846 0.842 0.845 0.838 0.901
0.65 0.781 0.784 0.787 0.772 0.775 0.779 0.857
0.55 0.726 0.723 0.723 0.718 0.714 0.713 0.813
0.45 0.659 0.660 0.657 0.647 0.650 0.647 0.766
0.35 0.602 0.600 0.596 0.590 0.587 0.584 0.718
0.25 0.532 0.535 0.530 0.517 0.520 0.514 0.668
0.15 0.471 0.468 0.466 0.455 0.452 0.451 0.616
Table 1: πˆ0 estimates by the Storey, QBF, and EBF procedures in the simulation study. Each
entry indicates the average estimates for different π0 values taken over 20 simulated data sets.
For the Storey and the QBF procedures, the estimates are based on the permutation procedures;
the results obtained for different permutation numbers are also shown. All estimates satisfy the
upper bound requirement and they are not very sensitive to the number of permutations.
We then proceed to examine the realized false discovery and false non-discovery rates obtained
by the B-H, Storey, QBF, and EBF procedures. The results are summarized in Tables 2 and
3. Because the estimates of πˆ0 from the QBF procedure have only small variation for different
numbers of permutations, its realized FDP and FNP results are virtually invariant with respect
to the permutation numbers; therefore, we only report the results using πˆ0 estimated by 100
permutations. Contrary to the Bayesian procedures, the number of permutations directly impacts
the precision of the permutation p-values and consequently alters the outcomes of the p-value
based FDR control procedures. Such impacts can be severe especially when the value of π0 is
close to 1. In our experiment, when π0 = 0.95, with 500 permutations, neither the Storey nor
the B-H procedure is able to reject a single null hypothesis. The issue seems to be resolved by
performing more permutations; however, we have to pay a steep price in computations even in
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this simple setting.
Overall, all the methods maintain the desired level of FDR control, and their powers are quite
comparable (when the accurate p-values are provided to the Storey and B-H procedure). More
specifically, we note that
1. Results from the B-H and Storey procedures based on pbf provide benchmarks to compare
the frequentist and the Bayesian FDR controls in this setting. The Bayesian FDR controls
are expected to be more stringent, but the differences reflected by the realized FNPs are
mostly small (especially when π0 is close to 1).
2. The two test statistics (the Bayes factor and min-p) display very similar powers in gene-level
testing, however the Bayes factor performs slightly better.
FDP
π0 B-H (pminp) B-H (pbf ) Storey (pminp) Storey (pbf)
500 5000 500 5000 500 5000 500 5000 QBF EBF
0.95 0.000† 0.046 0.000† 0.043 0.000† 0.046 0.000† 0.043 0.050 0.035
0.85 0.033 0.043 0.031 0.043 0.033 0.047 0.031 0.048 0.039 0.028
0.75 0.031 0.036 0.029 0.036 0.042 0.042 0.041 0.043 0.031 0.021
0.65 0.028 0.032 0.026 0.032 0.038 0.041 0.040 0.042 0.029 0.020
0.55 0.025 0.028 0.025 0.028 0.038 0.039 0.038 0.038 0.025 0.017
0.45 0.021 0.022 0.021 0.022 0.032 0.034 0.033 0.034 0.022 0.014
0.35 0.018 0.018 0.017 0.018 0.029 0.030 0.029 0.030 0.020 0.013
0.25 0.012 0.013 0.011 0.012 0.023 0.024 0.024 0.024 0.016 0.009
0.15 0.007 0.008 0.007 0.008 0.016 0.016 0.016 0.017 0.011 0.006
Table 2: Realized FDPs yielded by the B-H, Storey, QBF, and EBF procedures in simulation
study II. Each entry is obtained by averaging over the 20 simulated data sets. The entries
annotated by “†” indicate that the corresponding method fails to reject any hypothesis.
Although all the procedures yield extremely similar statistical performance, they have striking
differences in computational efficiency. We benchmark the running time of a complete analysis
of a single simulated data set using various procedures. All of the procedures tested are imple-
mented in the C++ programming language and run on a machine with an 8-core Intel Xeon
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FNP
π0 B-H (pminp) B-H (pbf ) Storey (pminp) Storey (pbf)
500 5000 500 5000 500 5000 500 5000 QBF EBF
0.95 0.050† 0.034 0.050† 0.034 0.050† 0.034 0.050† 0.034 0.034 0.034
0.85 0.104 0.101 0.103 0.100 0.104 0.100 0.103 0.099 0.100 0.103
0.75 0.173 0.169 0.171 0.167 0.169 0.168 0.167 0.165 0.168 0.172
0.65 0.247 0.243 0.244 0.240 0.242 0.240 0.238 0.236 0.241 0.247
0.55 0.329 0.325 0.325 0.321 0.321 0.319 0.316 0.314 0.322 0.330
0.45 0.417 0.414 0.411 0.409 0.408 0.406 0.401 0.399 0.409 0.418
0.35 0.516 0.515 0.511 0.509 0.505 0.503 0.497 0.495 0.507 0.517
0.25 0.631 0.629 0.626 0.623 0.616 0.615 0.608 0.607 0.618 0.630
0.15 0.761 0.760 0.757 0.755 0.746 0.745 0.739 0.738 0.748 0.759
Table 3: Realized FNPs obtained by the B-H, Storey, QBF, and EBF procedures in simulation
study II. Each entry is obtained by averaging over the 20 simulated data sets. The entries
annotated by “†” indicate that the corresponding method fails to reject any hypothesis and the
FNP achieves the maximum value.
2.13GHz CPU. We present the results in Table 4. Given required p-values or Bayes factors,
the computations for various FDR control procedures are mostly trivial, the main difference in
computational time is primarily attributed to the cost in permutations.
EBF QBF (100) B-H/Storey (500) B-H/Storey (5000)
0m43s 3m34s 11m56s 114m34s
Table 4: Computational time measured for various FDR control procedures in simulation study
II. Numbers in parenthesis indicate the number of permutations performed for each procedure.
5 Real Data Application: Multi-tissue eQTL Discovery
In this section, we demonstrate the proposed statistical approach in a real data application
of mapping eQTL across multiple tissues. The aim of the multi-tissue eQTL mapping is to
investigate the commonality and the specificity of the eQTLs in different tissue environments.
Comparing to the single-tissue eQTL study described in the simulation study, expression levels
for each gene are collected in multiple tissue/cell types from the same set of unrelated individuals,
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and a joint eQTL analysis across all tissues is required. Within each tissue, we assume the same
statistical model as the linear model (4.1), however across tissues, the residual errors are generally
assumed to be correlated (Wen, 2014).
Our primary goal is still to identify genes harboring causal eQTLs (i.e., eGenes): let βijt denote
the association coefficient between expressions of gene i and its j-th genetic variant in tissue t.
For each gene i, we are interested in testing the following hypothesis:
H0 : βijt = 0, ∀ j, t vs. H1 : some βijt 6= 0. (5.1)
Clearly, the problem is even more challenging when considering the potential association patterns
across multiple tissues under the alternative scenario. First, multi-tissue data allow identifying
association signals that might be modest but consistent across tissues. To achieve this iden-
tification, it requires a framework analogous to a meta-analysis that jointly models potential
associations across tissue types. Secondly, it is known that a proportion of eQTLs are only ac-
tive in specific tissue types (i.e., βijt 6= 0 only for some t). To account for this, we must explicitly
address the configurations of possible association activities across multiple tissues.
In Dimas et al. (2009), the authors used a naive gene-level test statistic Ti = minj,t pijt , where
each pijt is the p-value from a single association test for each gene-genetic variant pair in each
tissue type. The p-value of the overall test statistic, Ti, must be evaluated in a very complicated
permutation scheme to account for intra-individual correlations of gene expression levels and the
LD in genetic variants. Apparently, this naive test statistic does not fully capture the alternative
scenarios discussed above and is expected to lose power. In brief, to the best of our knowledge,
there is no frequentist approach that can produce appropriate p-values to test (5.1).
Recently, Flutre et al. (2013) proposed a full parametric Bayesian model to explicitly describe
all possible alternative scenarios and derived a Bayes factor to efficiently test eGenes, taking
advantage of Bayesian model averaging. More specifically, for eQTL data collect from T different
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tissues, they consider all 2T −1 possible configurations of association activities for each potential
associated SNP (e.g., a configuration (1, 1, ..., 1) indicates the eQTL is active in all tissues).
For each given configuration, a Bayes factor can be computed analytically accounting for the
similarity and heterogeneity of the genetic effect sizes (βijt ’s) of each active association in different
tissues (Wen and Stephens, 2014). The probability weights on each type of the total (2T−1) non-
zero configuration model are then estimated using an EM algorithm by pooling information across
all available gene-SNP data across the genome. Given the resulting weights on configurations
and the “(at most) one causal association per cis region” assumption, a weighted Bayes factor
is evaluated using Bayesian model averaging. Note that the weighted Bayes factor itself is a
well-defined Bayes factor and can be plugged into the proposed EBF and QBF procedures.
Flutre et al. (2013) convincingly demonstrated that the resulting Bayes factor is much more
powerful than the naive test statistic Ti = minj,t pijt . Nevertheless, to apply a multiple testing
procedure for identifying eGenes, they had to rely on permutation procedures to obtain p-values
by treating the resulting Bayes factors as the frequentist test statistics.
We apply both the EBF and the QBF procedures to a real multiple tissue eQTL data set that
was originally published in Dimas et al. (2009) and re-analyzed by Flutre et al. (2013). In the
experiment, 75 unrelated Western European individuals are genotyped. Expression levels from
this set of individuals were measured genome-wide in primary fibroblasts, Epstein-Barr virus-
immortalized B cells (LCLs), and T cells. The expression data went through quality control
and normalization steps (by Dimas et al. (2009)), and a subset of 5,012 genes that were deemed
highly expressed in all three cell types is selected for eQTL analysis.
Based on the Bayes factor derived in Flutre et al. (2013), the QBF (in which πˆ0 is estimated
with only 100 permutations) and EBF procedures identify 1002 and 927 eGenes, respectively,
at a Bayesian FDR level of 5%. In comparison, Flutre et al. (2013) identified 1012 eGenes by
applying the Storey procedure using the permutation p-values of the Bayes factors (with 10,000
permutations) also at an FDR level of 5%. Although the three methods yield similar results,
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the EBF and the QBF procedures achieve dramatic computational time reduction by avoiding
large amounts of permutations. Finally, Flutre et al. (2013) noted that Storey’s procedure based
on permutation p-values of the naive Ti statistics (with 10,000 permutations) only identified
627 eGenes. Among those eGenes, 592 genes(or 94%) are also identified by the EBF and QBF
approaches.
6 Discussion
We have introduced a Bayesian FDR control procedure with Bayes factors that is robust to mis-
specifications of alternative models. This feature should provide peace of mind for practitioners
who are attempting parametric Bayesian models in multiple hypothesis testing. Nevertheless,
within our framework, the model specification still dictates the overall performance, e.g., a badly
designed alternative model would have very little power and would therefore be useless. Our
central message throughout this paper has been that various FDR control procedures have little
practical difference if the same or similar test statistics are applied; however, our proposed pro-
cedure encourages well-designed parametric modeling approaches to obtain more powerful test
statistics.
Another advantage of our approach is its computational efficiency, especially when compared with
the alternative method’s reliance on permutation p-values. However, this statement assumes the
Bayes factors can be easily evaluated. Many previous and ongoing works have been devoted to
efficient evaluation and approximation of Bayes factors in various model systems. In particular,
Johnson (2005) demonstrated that almost all the well-known frequentist test statistics (e.g., z, F ,
and χ2 statistics) can be “translated” into corresponding Bayes factors analytically, and Wen
(2014) demonstrated that Bayes factors can be analytically approximated in a general linear
model system that includes multiple linear regression, multivariate linear regression models, and
many others as special cases.
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Our proposed procedure bears certain similarities to the local fdr procedure (Efron et al., 2001,
Sun and Cai, 2007). However, it should be noted that the two procedures differ significantly in
the following two aspects. First, our procedure utilizes Bayes factors as test statistics whereas
local fdr procedure relies on z-statistics. We note that in complex parametric modeling settings,
z-statistic is not always straightforwardly defined (e.g., in our eQTL mapping examples). Second,
the local fdr procedure is an empirical Bayes approach: it plugs in the MLE of π0 instead of
performing full Bayesian inference on π0. As discussed in this paper, this approach can be
susceptible to model misspecifications. In contrast, our proposed approach is robust to model
specification, and philosophically is fully Bayesian by viewing πˆ0 as a conservative approximation
(by a point mass) to the posterior distribution of π0.
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Appendix
A Proof of Proposition 1
Proof. Suppose that the true generative distributions of Y i under the null and alternative model
are given by p0
∗
i and p
1∗
i , respectively. As sample size ni is sufficiently large for each test, the
true Bayes factor, BF∗i , has the following properties
BF∗i
P
−→ 0, if Y i ∼ p
0∗
i ,
and
BF∗i
P
−→∞, if Y i ∼ p
1∗
i .
(A.1)
Assumption 1, in contrast, only requires that the assumed Bayes factors satisfy
BFi
P
−→ 0, if Y i ∼ p
0∗
i . (A.2)
Under the conditions stated in Assumption 2, Pr (πˆ0 ≥ π0 | π0)→ 1 implies that Pr (πˆ0 ≥ π0 | Y)→
1 for an arbitrary prior distribution on π0. Let ǫ := Pr (πˆ0 < π0 | Y). Then, it follows that
ǫ
P
−→ 0, as the number of null tests is sufficiently large. (A.3)
Importantly, the large number of the null tests is required for ensuring the upper bound property
of πˆ0.
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Consequently,
Pr(Zi = 0 | Y) =
∫
π0
π0 + (1− π0)BF
∗
i
p(π0 | Y i) d π0
=
∫
pi0≤pˆi0
π0
π0 + (1− π0)BF
∗
i
p(π0 | Y i) d π0 +
∫
pi0>pˆi0
π0
π0 + (1− π0)BF
∗
i
p(π0 | Y i) d π0
≤
πˆ0
πˆ0 + (1− πˆ0)BF
∗
i
+ ǫ
(A.4)
By (A.1), as ni →∞,
πˆ0
πˆ0 + (1− πˆ0)BF
∗
i
P
−→ I{Y i ∼ p
0∗
i }+ 0 · I{Y i ∼ p
1∗
i } (A.5)
whereas by (A.2),
πˆ0
πˆ0 + (1− πˆ0)BFi
P
−→ 1, if Y i ∼ p
0∗
i ,
πˆ0
πˆ0 + (1− πˆ0)BFi
≥ 0, if Y i ∼ p
1∗
i .
(A.6)
Hence,
lim
n→∞
Pr
(
πˆ0
πˆ0 + (1− πˆ0)BFi
≥
πˆ0
πˆ0 + (1− πˆ0)BF
∗
i
)
= 1, (A.7)
and by (A.3) and (A.4), each individual test satisfies
lim
ni→∞
Pr ((1− vˆi) ≥ Pr(Zi = 0 | Y i)) = 1 (A.8)
The decision rule stated in the Proposition 1 yields a true Bayesian FDR
FDR =
∑m
i=1 δ
†
i Pr(Zi = 0 | Y i)
D† ∨ 1
. (A.9)
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By (A.8), it is clear that
lim
n→∞
Pr
(
FDR ≤
∑m
i=1 δ
†
i (1− vˆi)
D† ∨ 1
)
= 1. (A.10)
Therefore, the Bayesian FDR can be consistently controlled. Furthermore, controlling
∑m
i=1 δ
†
i
(1−vˆi)
D†∨1
≤
α ensures that
FDR = E(FDR) ≤ E
(∑m
i=1 δ
†
i (1− vˆi)
D† ∨ 1
)
≤ α, (A.11)
because FDR is obviously bounded.
B Proof of Lemma 2
Proof. Let (BF(1), . . . ,BF(m)) denote the order statistics from the m Bayes factors that are all
generated from the respective null hypotheses. LetMj :=
1
j
∑j
i=1 BF(i) denote the partial sample
mean computed by the EBF procedure. Note that the sequence M1,M2, . . . is monotonically
non-decreasing. Furthermore, by the law of large numbers and the result of Lemma 1, it follows
that
Mm
P
−→ 1, (B.1)
for sufficiently large m.
In the case that d0 < m, it must be true that
1 ≤Md0+1 ≤Mm
P
−→ 1.
Because the truncated sample mean from the order statistics (BF(d0+1), ...,BF(m)) converges to a
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quantity that is strictly greater than 1, their contribution to the overall sample mean, Mm, must
be negligible, i.e.,
m− d0
m
(
1
m− d0
m∑
j=d0+1
BF(j)
)
P
−→ 0.
Taken together, we have shown that
πˆ0 =
d0
m
P
−→ 1. (B.2)
C Proof of Proposition 2
Proof. In the general mixture case, let S0 denote the subset of Bayes factors whose data are
generated from the null models. Based on Lemma 2, applying the EBF procedure on S0 results
in an estimate
dS0
|S0|
P
−→ 1, (C.1)
where |S0| denotes the cardinality of S0. In the mixed samples, (C.1) suggests that
Md
S0
=
1
dS0
d
S0∑
j=1
BF(j) ≤ 1. (C.2)
The LHS should be strictly less than 1 if there exists small values of Bayes factors from the
alternative models.
Because the EBF procedure finds the largest subset whose sample mean is less than 1, it must
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hold true that
Pr(d0 ≥ dS0 | π0)→ 1, (C.3)
and thus we conclude that
Pr(πˆ0 ≥ π0 | π0)→ 1. (C.4)
D Proof of Corollary 1
Proof. Given a pre-defined FDR level α, the rejection threshold on the estimated false discovery
probabilities is given by
t†α = argmin
t
(∑m
i=1 δ
†
i (t)(1− vˆi)
D†(t) ∨ 1
≤ α
)
.
Equivalently when there is at least one rejection, the above rejection threshold implies that the
rejection set Ω := {i : vˆi > t
†
α} is the largest set such that
∑
i∈Ω Pr(Zi = 0 | Y i, πˆ0)
||Ω||
≤ α,
where Pr(Zi = 0 | Y i, πˆ0) = (1 − vˆi) and ||Ω|| = D
†(t†α) denotes the cardinality of the set Ω.
That is, the average estimated false rejection probability in the rejection set should be ≤ α.
Consequently, it implies that if the i-th test yields Pr(Zi = 0 | Y i, πˆ0) ≤ α, it must be included
in the rejection set (because Ω is the largest such set). Therefore, to prove the corollary, it is
sufficient to show that Pr(Zi = 0 | Y i, πˆ0) ≤ α, provided that BFi ≥
m
α
.
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Applying the EBF procedure, a single Bayes factor with the value exceeding m leads to
πˆ0 ≤ 1−
1
m
. (D.1)
This implies
Pr(Zi = 0 | Y i, πˆ0) ≤
1− 1
m
(1− 1
m
) + 1
m
BFi
≤
m− 1
m+ (m− 1)α
· α <
m− 1
m− 1 +mα
· α < α (D.2)
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